Chief Scientific Officer and Founder
Proteolix

Dr. Molineaux co-founded Proteolix in December 2003 and served as the Company’s Chief Scientific Officer.  From January 2006 until February 2009, she served as the Company’s Chief Executive Officer, at which time she transitioned back to the role of CSO with responsibility for all research, development and clinical affairs activities. Prior to joining Proteolix, Dr. Molineaux was Vice President, Biology at Rigel Pharmaceuticals from 2000 to 2003. Before that, she was Vice President, Biology at Praelux, and from 1994 through 1999, Dr. Molineaux served as Vice President of Drug Development at Praecis Pharmaceuticals. From 1989 until 1994 she was a scientist in the Immunology group at Merck, in Rahway, NJ. Dr. Molineaux received a B.S. in Biology from Smith College, a Ph.D. in Molecular Biology from Johns Hopkins University, and completed a postdoctoral fellowship at Columbia University.